Retatrutide (LY-3437943) is a novel research peptide that functions as a triple agonist, targeting GLP-1, GIP, and glucagon receptors. This compound has shown promising results in preclinical studies for metabolic research applications.
The peptide appears as a white crystalline powder with high purity (>99%) when analyzed by HPLC. Retatrutide demonstrates stability when stored properly in cool, dry conditions away from direct light.
As a research chemical, Retatrutide offers scientists an interesting compound for studying metabolic pathways and potential therapeutic applications. The peptide's unique triple agonist mechanism makes it particularly valuable for investigating new approaches to metabolic regulation.
Researchers should note that this product is intended for laboratory research purposes only and not for human consumption. Proper safety protocols should always be followed when handling research peptides.
The product is available in convenient 5mg and 10mg quantities to accommodate various research needs. Each batch is accompanied by comprehensive analytical documentation including HPLC purity reports.